Ernal, Ethan Jay D.

HRN: 22-70-78  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/13/2023
03/19/2023
IV
110mg
OD
Pcap C
Waiting Final Action 
03/13/2023
CEFTRIAXONE 1G (VIAL)
03/13/2023
03/19/2023
IV
780mg
Q24
Pcap C
Waiting Final Action 
03/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/15/2023
03/29/2023
IV
390mg
Q6hrs
Pcap Severe
Waiting Final Action 
03/23/2023
CIPROFLOXACIN 500MG (TAB)
03/23/2023
03/30/2023
ORALLY VIA OGT
115mg Pptab
BID
PCAP C
Waiting Final Action 
03/24/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/24/2023
03/30/2023
IVT
110mg
OD
PCAP D
Waiting Final Action 
03/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/24/2023
03/30/2023
IVT
390mg
Q6
PCAP D
Waiting Final Action 
03/24/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/24/2023
03/30/2023
IVT
47mg
OD
PCAP
Waiting Final Action 
03/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/25/2023
03/31/2023
IVT
60mg
Q6
HCAI
Waiting Final Action 
03/28/2023
CLINDAMYCIN 150MG (CAP)
03/28/2023
04/04/2023
PPTB
60mg
Q8hrs
Pcap D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: